Trident Lifeline

{
  "main_header": {
    "sid": 1003715,
    "name": "Trident Lifeline",
    "stock_name": "Trident Lifeline",
    "full_name": "Trident Lifeline Ltd",
    "name_url": "stocks-analysis/trident-lifeline",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "257.90",
    "chg": -6.15,
    "chgp": "-2.33%",
    "dir": -1,
    "prev_price": "264.05",
    "mcapval": "315.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 543616,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE0MKA01014",
    "curr_date": "Aug 04, 03:30 PM",
    "curr_time": "01:42 AM",
    "last_traded_at": "Aug 04, 03:30 PM IST",
    "bse_nse_vol": 35400,
    "exc_status": "Active",
    "traded_date": "Aug 04, 2026",
    "traded_date_str": "2026 08 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/trident-lifeline-1003715-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Trident Lifeline Ltd Downgraded to Sell Amid Mixed Financial and Quality Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/trident-lifeline-ltd-downgraded-to-sell-amid-mixed-financial-and-quality-signals-4133073",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/TridentLifeline_mojoScore_4133073.png",
        "date": "2026-08-03 08:13:31",
        "description": "Trident Lifeline Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 31 July 2026. Despite positive financial trends and an attractive valuation, concerns over quality metrics and institutional participation have weighed on the stock’s outlook, prompting a reassessment of its investment appeal."
      },
      {
        "title": "Trident Lifeline Ltd Downgraded to Sell as Quality Metrics Weaken",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/trident-lifeline-ltd-downgraded-to-sell-as-quality-metrics-weaken-4132757",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/TridentLifeline_qualitydot_4132757.png",
        "date": "2026-08-03 08:00:13",
        "description": "Trident Lifeline Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its quality grade downgraded from good to average as of 31 July 2026. This shift reflects changes in key business fundamentals including profitability metrics, debt levels, and operational efficiency. The downgrade accompanies a revised Mojo Score of 48.0 and a Sell rating, signalling caution for investors amid a challenging market backdrop and subdued stock performance."
      },
      {
        "title": "Trident Lifeline Ltd Gains 0.13%: Strong Growth and Valuation Shift Define Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/trident-lifeline-ltd-gains-013-strong-growth-and-valuation-shift-define-week-4131362",
        "imagepath": "",
        "date": "2026-08-01 11:03:44",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>27 Jul:</strong> Stock opens at Rs.262.15, dips slightly (-0.15%) despite Sensex rally</p>\n                    <p><strong>30 Jul:</strong> Strong quarterly growth reported; Mojo Grade upgraded to Hold; stock rises to Rs.269.00 (+1.30%)</p>\n                    <p><strong>31 Jul:</strong> Valuation turns attractive amid sector challenges; stock retreats to Rs.262.90 (-2.27%)</p>\n                    <p><strong>Week Summary:</strong> Stock closes at Rs.262.90, up 0.13% vs Sensex +2.39%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.262.55</div></div>\n      ..."
      },
      {
        "title": "Trident Lifeline Ltd Valuation Turns Attractive Amid Sector Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/trident-lifeline-ltd-valuation-turns-attractive-amid-sector-challenges-4129487",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/TridentLifeline_valuationdot_4129487.png",
        "date": "2026-07-31 08:01:09",
        "description": "Trident Lifeline Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating, signalling a potential opportunity for investors amid a mixed performance in the Pharmaceuticals & Biotechnology sector. This upgrade comes alongside a recent improvement in the company’s Mojo Grade from Sell to Hold, reflecting a cautiously optimistic outlook supported by improved price-to-earnings and price-to-book ratios relative to its peers."
      },
      {
        "title": "Trident Lifeline Ltd Reports Strong Quarterly Growth, Upgrades Mojo Grade to Hold",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/trident-lifeline-ltd-reports-strong-quarterly-growth-upgrades-mojo-grade-to-hold-4128739",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/TridentLifeline_fintrenddot_4128739.png",
        "date": "2026-07-30 12:00:10",
        "description": "Trident Lifeline Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has demonstrated a marked improvement in its financial performance for the quarter ended June 2026. The company’s financial trend has shifted from flat to positive, prompting an upgrade in its Mojo Grade from Sell to Hold as of 6 July 2026. This article analyses the recent quarterly results in the context of historical trends and market performance."
      },
      {
        "title": "Trident Lifeline Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/trident-lifeline-ltd-is-rated-sell-4125642",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/TridentLifeline_mojoScore_4125642.png",
        "date": "2026-07-29 10:11:32",
        "description": "Trident Lifeline Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 July 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Trident Lifeline Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/trident-lifeline-ltd-is-rated-sell-4106933",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/TridentLifeline_mojoScore_4106933.png",
        "date": "2026-07-18 10:10:51",
        "description": "Trident Lifeline Ltd is rated Sell by MarketsMOJO, with this rating last updated on 06 July 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 18 July 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Trident Lifeline Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/trident-lifeline-ltd-is-rated-sell-4092151",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/TridentLifeline_mojoScore_4092151.png",
        "date": "2026-07-07 10:10:40",
        "description": "Trident Lifeline Ltd is rated Sell by MarketsMOJO, with this rating last updated on 06 July 2026. While the rating change occurred on that date, the analysis and financial metrics presented here reflect the stock’s current position as of 07 July 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Trident Lifeline Ltd Upgraded to Hold as Technicals Improve Amid Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/trident-lifeline-ltd-upgraded-to-hold-as-technicals-improve-amid-mixed-financial-signals-4073853",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/TridentLifeline_mojoScore_4073853.png",
        "date": "2026-06-26 08:18:04",
        "description": "Trident Lifeline Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 25 June 2026. This revision reflects a nuanced improvement across technical indicators, valuation metrics, financial trends, and overall quality assessments, signalling a cautious but more optimistic outlook for investors."
      }
    ],
    "total": 159,
    "sid": "1003715",
    "stock_news_url": "https://www.marketsmojo.com/news/trident-lifeline-1003715"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
      "datetime": "03-Aug-2026",
      "details": "Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed herewith Earnings Presentation for the Quarter ended 30th June 2026. (Q1 & FY27).",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "31-Jul-2026",
      "details": "In accordance with Regulation 47 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations we hereby enclose copies of newspaper advertisement published on July 31 2026 regarding extract of the Un-Audited Standalone and Consolidated Financial Statements for the Quarter ended 30th June 2026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 29.07.2026",
      "datetime": "29-Jul-2026",
      "details": "Outcome of Board Meeting held on 29.07.2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Trident Lifeline Ltd Downgraded to Sell Amid Mixed Financial and Quality Signals

2026-08-03 08:13:31

Trident Lifeline Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 31 July 2026. Despite positive financial trends and an attractive valuation, concerns over quality metrics and institutional participation have weighed on the stock’s outlook, prompting a reassessment of its investment appeal.

Read full news article

Trident Lifeline Ltd Downgraded to Sell as Quality Metrics Weaken

2026-08-03 08:00:13

Trident Lifeline Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its quality grade downgraded from good to average as of 31 July 2026. This shift reflects changes in key business fundamentals including profitability metrics, debt levels, and operational efficiency. The downgrade accompanies a revised Mojo Score of 48.0 and a Sell rating, signalling caution for investors amid a challenging market backdrop and subdued stock performance.

Read full news article

Trident Lifeline Ltd Gains 0.13%: Strong Growth and Valuation Shift Define Week

2026-08-01 11:03:44

Key Events This Week

27 Jul: Stock opens at Rs.262.15, dips slightly (-0.15%) despite Sensex rally

30 Jul: Strong quarterly growth reported; Mojo Grade upgraded to Hold; stock rises to Rs.269.00 (+1.30%)

31 Jul: Valuation turns attractive amid sector challenges; stock retreats to Rs.262.90 (-2.27%)

Week Summary: Stock closes at Rs.262.90, up 0.13% vs Sensex +2.39%

Week Open

Rs.262.55

...

Read full news article

Trident Lifeline Ltd Valuation Turns Attractive Amid Sector Challenges

2026-07-31 08:01:09

Trident Lifeline Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating, signalling a potential opportunity for investors amid a mixed performance in the Pharmaceuticals & Biotechnology sector. This upgrade comes alongside a recent improvement in the company’s Mojo Grade from Sell to Hold, reflecting a cautiously optimistic outlook supported by improved price-to-earnings and price-to-book ratios relative to its peers.

Read full news article

Trident Lifeline Ltd Reports Strong Quarterly Growth, Upgrades Mojo Grade to Hold

2026-07-30 12:00:10

Trident Lifeline Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has demonstrated a marked improvement in its financial performance for the quarter ended June 2026. The company’s financial trend has shifted from flat to positive, prompting an upgrade in its Mojo Grade from Sell to Hold as of 6 July 2026. This article analyses the recent quarterly results in the context of historical trends and market performance.

Read full news article

Trident Lifeline Ltd is Rated Sell

2026-07-29 10:11:32

Trident Lifeline Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 July 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Trident Lifeline Ltd is Rated Sell

2026-07-18 10:10:51

Trident Lifeline Ltd is rated Sell by MarketsMOJO, with this rating last updated on 06 July 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 18 July 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Trident Lifeline Ltd is Rated Sell

2026-07-07 10:10:40

Trident Lifeline Ltd is rated Sell by MarketsMOJO, with this rating last updated on 06 July 2026. While the rating change occurred on that date, the analysis and financial metrics presented here reflect the stock’s current position as of 07 July 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Trident Lifeline Ltd Upgraded to Hold as Technicals Improve Amid Mixed Financial Signals

2026-06-26 08:18:04

Trident Lifeline Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 25 June 2026. This revision reflects a nuanced improvement across technical indicators, valuation metrics, financial trends, and overall quality assessments, signalling a cautious but more optimistic outlook for investors.

Read full news article

View All News